JPWO2023037868A1 - - Google Patents
Info
- Publication number
- JPWO2023037868A1 JPWO2023037868A1 JP2023546868A JP2023546868A JPWO2023037868A1 JP WO2023037868 A1 JPWO2023037868 A1 JP WO2023037868A1 JP 2023546868 A JP2023546868 A JP 2023546868A JP 2023546868 A JP2023546868 A JP 2023546868A JP WO2023037868 A1 JPWO2023037868 A1 JP WO2023037868A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/33—Fibroblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021146130 | 2021-09-08 | ||
| PCT/JP2022/031721 WO2023037868A1 (ja) | 2021-09-08 | 2022-08-23 | 線維芽細胞を含む腎疾患治療用医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2023037868A1 true JPWO2023037868A1 (https=) | 2023-03-16 |
Family
ID=85506601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023546868A Pending JPWO2023037868A1 (https=) | 2021-09-08 | 2022-08-23 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240316113A1 (https=) |
| EP (1) | EP4349349A4 (https=) |
| JP (1) | JPWO2023037868A1 (https=) |
| CN (1) | CN117750964A (https=) |
| AU (1) | AU2022344667A1 (https=) |
| CA (1) | CA3226199A1 (https=) |
| WO (1) | WO2023037868A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3211113A1 (en) * | 2021-03-04 | 2022-09-09 | Metcela Inc. | Lymphangiogenesis promoting factor-expressing fibroblast, and pharmaceutical composition containing same |
| CN119685401A (zh) * | 2024-06-03 | 2025-03-25 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 一种改造成纤维细胞的方法及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102407387B1 (ko) * | 2017-02-24 | 2022-06-10 | 가부시키가이샤 메토세라 | 섬유아세포를 포함하고, 심장 질환들의 치료를 위하여 사용될 수 있는 주사용 조성물, 및 치료 용도를 위하여 섬유아세포를 생산하는 방법 |
| CA3110831A1 (en) | 2018-08-29 | 2020-03-05 | Metcela Inc. | Method for producing fibroblast, and g-csf-positive fibroblast mass |
| WO2021133790A1 (en) * | 2019-12-26 | 2021-07-01 | Figene, Llc | Prevention and treatment of kidney failure by administration of fibroblasts and products thereof |
| CN115210361B (zh) * | 2020-03-04 | 2024-12-10 | 淋巴奥格尼克斯有限公司 | 促红细胞生成素产生能力增强的成纤维细胞、制造方法以及医药组合物 |
| CA3211113A1 (en) * | 2021-03-04 | 2022-09-09 | Metcela Inc. | Lymphangiogenesis promoting factor-expressing fibroblast, and pharmaceutical composition containing same |
-
2022
- 2022-08-23 JP JP2023546868A patent/JPWO2023037868A1/ja active Pending
- 2022-08-23 CA CA3226199A patent/CA3226199A1/en active Pending
- 2022-08-23 AU AU2022344667A patent/AU2022344667A1/en active Pending
- 2022-08-23 CN CN202280052893.7A patent/CN117750964A/zh active Pending
- 2022-08-23 EP EP22867190.5A patent/EP4349349A4/en not_active Withdrawn
- 2022-08-23 US US18/577,841 patent/US20240316113A1/en active Pending
- 2022-08-23 WO PCT/JP2022/031721 patent/WO2023037868A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN117750964A (zh) | 2024-03-22 |
| AU2022344667A1 (en) | 2024-01-25 |
| WO2023037868A1 (ja) | 2023-03-16 |
| EP4349349A4 (en) | 2025-05-21 |
| EP4349349A1 (en) | 2024-04-10 |
| US20240316113A1 (en) | 2024-09-26 |
| CA3226199A1 (en) | 2023-03-16 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240411 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20240904 |